Prostate cancer screening: Canadian guidelines 2011.
作者信息
Izawa Jonathan I, Klotz Laurence, Siemens D Robert, Kassouf Wassim, So Alan, Jordan John, Chetner Michael, Iansavichene Alla E
机构信息
Departments of Surgery & Oncology, Divisions of Urology & Surgical Oncology, The Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON;
出版信息
Can Urol Assoc J. 2011 Aug;5(4):235-40. doi: 10.5489/cuaj.11134.
Abstract
摘要
相似文献
1
Prostate cancer screening: Canadian guidelines 2011.前列腺癌筛查：2011年加拿大指南
Can Urol Assoc J. 2011 Aug;5(4):235-40. doi: 10.5489/cuaj.11134.
2
Are United States and Canadian cancer screening rates consistent with guideline information regarding the age of screening initiation?美国和加拿大的癌症筛查率是否与有关筛查起始年龄的指南信息一致？
Int J Qual Health Care. 2011 Dec;23(6):611-20. doi: 10.1093/intqhc/mzr050. Epub 2011 Sep 2.
4
5
Recent trends in prostate cancer in Canada.加拿大前列腺癌的最新趋势。
Health Rep. 2019 Apr 17;30(4):12-17. doi: 10.25318/82-003-x201900400002-eng.
6
Recommendations by Canadian urologists and radiation oncologists for the treatment of clinically localized prostate cancer.加拿大泌尿科医生和放射肿瘤学家关于临床局限性前列腺癌治疗的建议。
Can Urol Assoc J. 2008 Jun;2(3):197-203. doi: 10.5489/cuaj.592.
7
Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.前列腺癌筛查：美国医师学院临床指南委员会的指导声明。
Ann Intern Med. 2013 May 21;158(10):761-769. doi: 10.7326/0003-4819-158-10-201305210-00633.
8
[Quality assessment of global prostate cancer screening guidelines].[全球前列腺癌筛查指南的质量评估]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Feb 10;42(2):227-233. doi: 10.3760/cma.j.cn112338-20200806-01033.
9
Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.争议中的前列腺癌筛查：加拿大男性的知识、信念、利用情况及未来意向
Can J Public Health. 1997 Sep-Oct;88(5):327-32. doi: 10.1007/BF03403900.
引用本文的文献
1
Developments in Ultrasound-Based Imaging for Prostate Cancer Detection.基于超声成像技术在前列腺癌检测中的进展
Prostate. 2025 Jun;85(9):823-832. doi: 10.1002/pros.24893. Epub 2025 Mar 28.
2
Robotically controlled three-dimensional micro-ultrasound for prostate biopsy guidance.机器人控制的三维微超声在前列腺活检中的引导作用。
Int J Comput Assist Radiol Surg. 2023 Jun;18(6):1093-1099. doi: 10.1007/s11548-023-02869-3. Epub 2023 Mar 30.
3
Eight Days of Water-Only Fasting Promotes Favorable Changes in the Functioning of the Urogenital System of Middle-Aged Healthy Men.仅饮水 8 天即可促进中年健康男性泌尿生殖系统功能的有利变化。
Nutrients. 2020 Dec 30;13(1):113. doi: 10.3390/nu13010113.
4
A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy.前列腺癌成像、正电子发射断层扫描及放射性药物治疗综述。
Can Urol Assoc J. 2020 Apr;14(4):130-138. doi: 10.5489/cuaj.6506. Epub 2020 Apr 1.
5
Active treatment in low-risk prostate cancer: a population-based study.低危前列腺癌的积极治疗：一项基于人群的研究。
Curr Oncol. 2019 Aug;26(4):e535-e540. doi: 10.3747/co.26.4953. Epub 2019 Aug 1.
6
[Not Available].[无可用内容]
Can Fam Physician. 2018 May;64(5):e225-e231.
7
Choosing guidelines to use in your practice.选择在你的实践中使用的指南。
Can Fam Physician. 2018 May;64(5):357-362.
8
Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.数字直肠检查用于初级保健中的前列腺癌筛查：系统评价和荟萃分析。
Ann Fam Med. 2018 Mar;16(2):149-154. doi: 10.1370/afm.2205.
9
PSA screening: Time to overcome our brand confusion.前列腺特异性抗原（PSA）筛查：是时候克服我们的品牌认知混乱了。
Can Urol Assoc J. 2017 Oct;11(10):295-296. doi: 10.5489/cuaj.4913.
10
Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.能否覆水难收？影响癌症筛查决策的情感因素定性研究。
BMC Cancer. 2017 Sep 13;17(1):647. doi: 10.1186/s12885-017-3596-7.
本文引用的文献
1
The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study.度他雄胺对前列腺特异性抗原在先前阴性前列腺活检男性中诊断高级别和临床相关前列腺癌的有用性的影响：来自 REDUCE 研究的结果。
J Urol. 2011 Jan;185(1):126-31. doi: 10.1016/j.juro.2010.09.011. Epub 2010 Nov 12.
2
Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic test.在预筛选男性中，前列腺癌抗原 3（PCA3）基因和前列腺特异性抗原的表现：探索 PCA3 作为一线诊断检测的价值。
Eur Urol. 2010 Oct;58(4):475-81. doi: 10.1016/j.eururo.2010.06.039. Epub 2010 Jul 9.
3
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.哥德堡随机人群前列腺癌筛查试验的死亡率结果。
Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.
4
Is extended and saturation biopsy necessary?是否需要进行扩展和饱和活检？
Int J Urol. 2010 May;17(5):432-47. doi: 10.1111/j.1442-2042.2010.02479.x.
5
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.前列腺癌：3T 多参数磁共振成像检测的价值——与组织病理学相关性。
Radiology. 2010 Apr;255(1):89-99. doi: 10.1148/radiol.09090475.
6
Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.经直肠超声引导前列腺活检后泌尿系统并发症住院率升高。
J Urol. 2010 Mar;183(3):963-8. doi: 10.1016/j.juro.2009.11.043. Epub 2010 Jan 20.
7
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.局限性前列腺癌大样本主动监测队列长期随访的临床结果。
J Clin Oncol. 2010 Jan 1;28(1):126-31. doi: 10.1200/JCO.2009.24.2180. Epub 2009 Nov 16.
8
Prostate specific antigen best practice statement: 2009 update.前列腺特异性抗原最佳实践声明：2009年更新版
J Urol. 2009 Nov;182(5):2232-41. doi: 10.1016/j.juro.2009.07.093. Epub 2009 Sep 24.
9
A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.基于风险的策略可提高基于前列腺特异性抗原的前列腺癌检测效果。
Eur Urol. 2010 Jan;57(1):79-85. doi: 10.1016/j.eururo.2009.08.025. Epub 2009 Sep 1.
10
Techniques and predictive models to improve prostate cancer detection.改善前列腺癌检测的技术和预测模型。
Cancer. 2009 Jul 1;115(13 Suppl):3085-99. doi: 10.1002/cncr.24357.
Zotero 插件